Evidence map›Paper›PMID 36288275›Full record

ArticlePloS one2022

Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.

Chungah Kim, Antony Chum, Andrew Nielsen, Sara Allin, Tarra L Penney, Katherine Rittenbach, Frank P MacMaster, Patricia O'Campo

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chungah KimYork University, School of Kinesiology and Health Sciences, Toronto, Ontario, Canada.ORCID 0000-0002-9033-3874
Antony ChumYork University, School of Kinesiology and Health Sciences, Toronto, Ontario, Canada.ORCID 0000-0002-6756-7031
Andrew NielsenCanadian Institute for Health Information, Toronto, Ontario, Canada.
Sara AllinUniversity of Toronto, Dalla Lana School of Public Health, Toronto, Ontario, Canada.ORCID 0000-0002-0579-8985
Tarra L PenneyYork University Faculty of Health, School of Global Health, Toronto, Ontario, Canada.
Katherine RittenbachAlberta Health Services, Strategic Clinical Networks, Edmonton, Alberta, Canada.ORCID 0000-0001-6791-4091
Frank P MacMasterAlberta Health Services, Strategic Clinical Networks, Edmonton, Alberta, Canada.
Patricia O'CampoUnity Health Toronto, MAP Centre for Urban Health Solutions, Toronto, Ontario, Canada.

Funding

CIHR FRN 173447
6 · The paper itself

Abstract

Legalization of recreational cannabis in Ontario included the legalization of flower and herbs (Phase 1, October 2018), and was followed by the deregulation of cannabis retailers and sales of edibles (Phase 2, February 2020). Research on the impact of cannabis legalization on acute care utilization is nascet; no research has investigated potential age, gender, and geographically vulnerable subgroup effects. Residents living in Northern Ontario not only have higher levels of substance use problems, but also have inadequate access to primary healthcare. Our study investigated the impact of Ontario's recreational cannabis policy (including Phase 1 and 2) on cannabis-attributable emergency department (ED) visits, and estimated the impact separately for different age and gender groups, with additional analyses focused on Northern Ontarians. We created a cohort of adults (18 and over) eligible for provincial universal health insurance with continuous coverage from 2015-2021 (n = 14,900,820). An interrupted time series was used to examine the immediate impact and month-to-month changes in cannabis-related ED visits associated with Phase 1 & 2 for each subgroup. While Northern Ontario has higher rates of cannabis-related ED visits, both Northern and Southern Ontario show similar patterns of changes. Phase 1 was associated with significant increases in adults 25-64, with the strongest increases seen in women 45-64. Month-to-month trends were flattened in most groups compared to pre-legalization. Phase 2 was associated with significant immediate increases for adults aged 18-44 in both genders, but the increases were larger in women than men. No significant month-to-month changes were detected in this period. While current preventive efforts are largely focused on reducing cannabis-related harms in youths and younger adults, our results show that adults 25-64, particularly women, have been significantly impacted by cannabis policies. Further research on gender-specific cannabis dosage and targeted interventions for adult women should be investigated. Legalization did not appear to have a differential impact on Northern versus Southern Ontario, but higher rates of ED visits in the North should be addressed.

Indexed as

CannabisAdolescentAdultCanadaCannabinoid Receptor AgonistsEmergency Service, HospitalFemaleHumansInterrupted Time Series AnalysisLegislation, DrugMaleOntarioCannabinoid Receptor Agonists

Identifiers

PMID36288275
PMCPMC9604957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.